Long-acting injectable antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
August 26, 2019
MedinCell receives funding for the second formulation phase of its 6-month injectable contraceptive
January 24, 2019
MedinCell receives grant to develop long-acting injectable contraceptive
December 7, 2017
